Program Description
Advances in treatments for beta thalassemia have extended the lifespan of patients. Treatment and management strategies depend on the severity of disease, though standard of care therapies generally include regular blood transfusions and iron chelation therapy. Pharmacists are crucial members of the multidisciplinary care team and can assist in improving access to therapy and transitions of care for patients to improve quality of life. This activity will equip pharmacists with counseling pearls to educate patients and caregivers about beta thalassemia treatment options, risk factors, and adverse effects of therapy.
Target audience: Health-system pharmacists, specialty pharmacists
Type of activity: Application
Release date: June 15, 2022
Expiration date: August 15, 2022
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, pharmacists will be able to:
- Examine the etiology and pathophysiology of beta thalassemia, including the difference between transfusion dependent and non-transfusion dependent disease
- Compare the emerging treatments including their mechanisms of action and clinical trial data as well as factors affecting the utilization of therapies in the care of patients with beta thalassemia
- Provide personalized education for patients about their disease and the treatments they are receiving
Alexis Kuhn, PharmD, BCOP
Pediatric Oncology Pharmacist- Ambulatory Services
Mayo Clinic
Assistant Professor of Pharmacy
Mayo Clinic College of Medicine
Rochester, Minnesota
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity numbers 0290-0000-22-313-L01-P. The activity is available for CE credit through August 15, 2022.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, watch the presentation in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty
Alexis Kuhn, PharmD, BCOP
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Abigail Dill; Susan Pordon; Brianna Winters; and Chloe Taccetta
An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms